AWH News and Press, Aspira Women's Health Inc. From 05/12/21

AUSTIN, Texas, May 12, 2021 (GLOBE NEWSWIRE) -- Aspira Women’s Health, Inc. (Nasdaq: AWH), a bioanalytical-based women’s health company focused on gynecologic disease and The Feinstein Institutes for Medical Research, the science arm of Northwell Health, the largest privat...

AUSTIN, Texas, May 11, 2021 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (Nasdaq: AWH), a bioanalytical-based women’s health company, today announced the appointment of a new member to its leadership team, Greg Richard. Greg Richard has joined the company as the Head of Corp...

AUSTIN, Texas, May 05, 2021 (GLOBE NEWSWIRE) -- Aspira Women’s Health, Inc. (Nasdaq: AWH), a bioanalytical-based women’s health company, today announced that it will report financial results for the first quarter ended March 31, 2021 on Thursday, May 13, 2021, after the market...

Aspira Women's Health (AWH) has extended the post-market gains with a ~12.2% rise in the pre-market as analysts weigh in on its new agreement to develop an early detection test for ovarian cancer.“We support the notion of the team taking another big swing and working to ...

Wah Fu Education Group (WAFU) +82%.180 Life Sciences (ATNF) +49%.NextDecade Corporation (NEXT) +31% on signing term sheet with Occidental Petroleum.Four Seasons Education (Cayman) (FEDU) +26%.Banco Santander Mexico SA ADR (BSMX) +19%.China Liberal Education Holdings Limited (CLEU) +18%.L...

Image source: The Motley Fool. Aspira Women's Health Inc. (NASDAQ: AWH) Q4 2020 Earnings Call Mar 25, 2021 , 4:30 p.m. ET Operator Continue reading For further details see: Aspira Women's Health Inc. (AWH) Q4 2020 Earnings Call Transcript...

Aspira Women's Health Inc. (AWH) Q4 2020 Earnings Conference Call March 25, 2021, 04:30 PM ET Company Participants Valerie Palmieri - President and CEO Robert Beechey - CFO Kaile Zagger - COO Lesley Northrop - Chief Scientific Officer Elena Ratner - Global Chief Medical Advisor and Clinical a...

Aspira Women's Health (AWH) has brokered an agreement with Dana-Farber Cancer Institute, Brigham and Women’s Hospital, and Medical University Lodz to evaluate microRNA (miRNA) technology for the development of a high-risk early detection test for ovarian cancer.The company says develop...

Aspira Women’s Health (AWH): Q4 GAAP EPS of -$0.58 misses by $0.54.Revenue of $1.45M (+10.7% Y/Y) beats by $0.15M.The Company ended the year with approximately $16.6 million in cash. Cash utilization in the fourth quarter of 2020 was $4.205 million, compared to $2.933 million in the pr...

AUSTIN, Texas, March 25, 2021 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira”) (Nasdaq: AWH), a bio-analytical based women’s health company focused on gynecologic disease, today reported its financial results for the fourth quarter and year ended Decembe...